Designing drugs that combat kidney damage.


INTRODUCTION Kidney disease remains one of the last worldwide frontiers in the field of non-communicable human disease. From 1990 to 2013, chronic kidney disease (CKD) was the top non-communicable cause of death with a greatest increase in global years of life lost while mortality of acute kidney injury (AKI) still hovers around 50%. This reflects the… (More)
DOI: 10.1517/17460441.2015.1033394


Cite this paper

@article{Ramos2015DesigningDT, title={Designing drugs that combat kidney damage.}, author={Adri{\'a}n Mario Ramos and Cristian Gonz{\'a}lez-Guerrero and Ana Bel{\'e}n Sanz and Maria Sanchez-Ni{\~n}o and Laura Rodr{\'i}guez-Osorio and Catalina Mart{\'i}n-Cleary and Beatriz Fern{\'a}ndez-Fern{\'a}ndez and Marta Ruiz-Ortega and Alberto Ortiz}, journal={Expert opinion on drug discovery}, year={2015}, volume={10 5}, pages={541-56} }